Registration number: 11926295

Inspire Neurocare Farnborough Limited
(formerly Hamberley Neurocare (Camberley) Limited)

Contents

Company Information	1
Balance Sheet	2
Notes to the Financial Statements	3 to 7

Inspire Neurocare Farnborough Limited
(formerly Hamberley Neurocare (Camberley) Limited)

Company Information

Directors

M D Gross D Kay T W Street

Registered office

10 Lower Thames Street London EC3R 6AF

Auditors

Hazlewoods LLP Windsor House Bayshill Road Cheltenham GL50 3AT

Inspire Neurocare Farnborough Limited
(formerly Hamberley Neurocare (Camberley) Limited)

(Registration number: 11926295)
Balance Sheet as at 31 December 2024

	Note	2024 £	Unaudited 2023 £
Fixed assets
Tangible assets	5	1,014,882	-
Current assets
Stocks		2,041	-
Debtors	6	760,795	100
Cash at bank and in hand		106,659	-
		869,495	100
Creditors: Amounts falling due within one year	7	(2,883,058)	-
Net current (liabilities)/assets		(2,013,563)	100
Total assets less current liabilities		(998,681)	100
Deferred tax liabilities		(150,289)	-
Net (liabilities)/assets		(1,148,970)	100
Capital and reserves
Called up share capital		100	100
Profit and loss account		(1,149,070)	-
Shareholders' (deficit)/funds		(1,148,970)	100

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss has been taken.

Approved and authorised by the Board on 29 September 2025 and signed on its behalf by:
 

M D Gross
Director

Inspire Neurocare Farnborough Limited
(formerly Hamberley Neurocare (Camberley) Limited)

Notes to the Financial Statements for the Year Ended 31 December 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The company was formerly known as Hamberley Neurocare (Camberley) Limited.

The address of its registered office is:
10 Lower Thames Street
London
EC3R 6AF

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Name of parent of group

These financial statements are consolidated in the financial statements of Magnus Topco Limited.

The financial statements of Magnus Topco Limited may be obtained from Companies House.

Going concern

Notwithstanding the net liability position shown on the balance sheet, the financial statements have been prepared on the going concern basis. The directors have considered the forecast cash flows and the cash requirements of the business in their assessment of going concern. As a result of this assessment it was concluded that the cash requirements of the business for the 12 months from signing will be met through a combination of operational cash flows and intergroup loans and thus the business is deemed to operate as a going concern.

The company is supported by loans from group undertakings and the directors have received assurances that the support will continue. The company is expected to become profitable in the forthcoming periods and the new owners are committed to achieving this through additional investment in the services which the company provides.

Judgements and estimation uncertainty

These financial statements do not contain any significant judgements or estimation uncertainty.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts and after eliminating sales within the company. The company recognises revenue when the amount of revenue can be reliably measured, it is probable that future economic benefits will flow to the entity and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises and deferred tax. Tax is recognised in the profit and loss account, except that a charge attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

Inspire Neurocare Farnborough Limited
(formerly Hamberley Neurocare (Camberley) Limited)

Notes to the Financial Statements for the Year Ended 31 December 2024

Deferred income tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Office equipment	Straight line over 3 years
Plant and machinery	25% straight line
Fixtures and fittings	25% straight line

Trade debtors

Trade debtors are amounts due from customers for services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. All trade debtors are repayable within one year and hence are included at the undiscounted cost of cash expected to be received. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the debtors.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and all are repayable within one year and hence are included at the undiscounted amount of cash expected to be paid.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Inspire Neurocare Farnborough Limited
(formerly Hamberley Neurocare (Camberley) Limited)

Notes to the Financial Statements for the Year Ended 31 December 2024

Financial instruments

Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.

 Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

 Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.

A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

The recoverable amount of goodwill is derived from measurement of the present value of the future cash flows of the cash-generating units ('CGUs') of which the goodwill is a part. Any impairment loss in respect of a CGU is allocated first to the goodwill attached to that CGU, and then to other assets within that CGU on a pro-rata basis.

Where indicators exist for a decrease in impairment loss, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised. Where a reversal of impairment occurs in respect of a CGU, the reversal is applied first to the assets (other than goodwill) of the CGU on a pro-rata basis and then to any goodwill allocated to that CGU.

For financial assets carried at amortised cost, the amount of an impairment is the difference between the asset’s carrying amount and the present value of estimated future cash flows, discounted at the financial asset’s original effective interest rate.

For financial assets carried at cost less impairment, the impairment loss is the difference between the asset’s carrying amount and the best estimate of the amount that would be received for the asset if it were to be sold at the reporting date.

Where indicators exist for a decrease in impairment loss, and the decrease can be related objectively to an event occurring after the impairment was recognised, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired financial asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was as follows:

	2024  No.	Unaudited 2023 No.
Average number of employees	17	3

Inspire Neurocare Farnborough Limited
(formerly Hamberley Neurocare (Camberley) Limited)

Notes to the Financial Statements for the Year Ended 31 December 2024

4

Taxation

Deferred tax

Deferred tax assets and liabilities

2024	Liability £
Fixed asset timing differences	150,801
Short term timing differences	(512)
	150,289

5

Tangible assets

	Land and buildings £	Furniture, fittings and equipment  £	Total £
Cost
At 1 January 2024	-	-	-
Additions	420,016	670,952	1,090,968
At 31 December 2024	420,016	670,952	1,090,968
Depreciation
At 1 January 2024	-	-	-
Charge for the year	3,067	73,019	76,086
At 31 December 2024	3,067	73,019	76,086
Carrying amount
At 31 December 2024	416,949	597,933	1,014,882
At 31 December 2023	-	-	-

6

Debtors

	2024 £	Unaudited 2023 £
Trade debtors	34,031	-
Prepayments	726,764	-
Other debtors	-	100
	760,795	100

Inspire Neurocare Farnborough Limited
(formerly Hamberley Neurocare (Camberley) Limited)

Notes to the Financial Statements for the Year Ended 31 December 2024

7

Creditors

	2024 £	Unaudited 2023 £
Due within one year
Trade creditors	41,014	-
Amounts due to group undertakings	2,760,557	-
Social security and other taxes	28,768	-
Outstanding defined contribution pension costs	5,463	-
Accruals	33,749	-
Deferred income	13,507	-
	2,883,058	-

8

Financial commitments, guarantees and contingencies

As at the balance sheet date, the company was party to a cross guarantee arrangement with OHF Camberley S.a.r.l. in relation to the leasehold property arrangement that it has entered into.

9

Obligations under leases and hire purchase contracts

Operating leases

The total of future minimum lease payments is as follows:

	2024 £	Unaudited 2023 £
Not later than one year	1,080,736	-
Later than one year and not later than five years	4,770,190	-
Later than five years	72,239,324	-
	78,090,250	-

10

Parent and ultimate parent undertaking

Until 31 October 2024, the company's immediate parent was Hamberley Care Homes Property Holding 1 S.a.r.l, and the ultimate parent company was UK Health Care Holdings 3 S.a.r.l., both companies incorporated in Luxembourg. Subsequent to this date, control passed to Magnus Acquisitions Limited, incorporated in England and Wales.

The ultimate controlling party since 1 November 2024 is Downing Group LLP, a Limited Liability Partnership incorporated in England and Wales.

The parent of the largest group in which these financial statements are consolidated is Magnus Topco Limited, incorporated in England and Wales.

11

Disclosure under Section 444 (5B) CA 2006

The Independent Auditor's Report was unqualified. The corresponding figures for the year ended 31 December 2023 shown in the financial statements are derived from the financial statements prepared for that period that were not audited. The name of the Senior Statutory Auditor who signed the audit report on 29 September 2025 was Simon Worsley, who signed for and on behalf of Hazlewoods LLP.